Genome-Wide Analysis of DNA Methylation and Acute Coronary Syndrome

Circulation Research

Volumn 120, Issue 11, 2017, Pages 1754-1767

  Li, Jun ^a,b   Zhu, Xiaoyan ^a   Yu, Kuai ^a   Jiang, Haijing ^a   Zhang, Yizhi ^a   Deng, Siyun ^a   Cheng, Longxian ^a   Liu, Xuezhen ^a   Zhong, Jia ^c   Zhang, Xiaomin ^a   He, Meian ^a   Chen, Weihong ^a   Yuan, Jing ^a   Gao, Ming ^a   Bai, Yansen ^a   Han, Xu ^a   Liu, Bing ^a   Luo, Xiaoting ^d   Mei, Wenhua ^d   He, Xiaosheng ^a   Sun, Shunchang ^e   Zhang, Liyun ^f   Zeng, Hesong ^a   Sun, Huizhen ^a   Liu, Chuanyao ^a   Guo, Yanjun ^a   Zhang, Bing ^a   Zhang, Zhihong ^a   Huang, Jinyan ^b   Pan, An ^a   Yuan, Yu ^a   Angileri, Francesca ^a   Ming, Bingxia ^a   Zheng, Fang ^a   Zeng, Qiutang ^a   Mao, Xiaobo ^a   Peng, Yudong ^a   Mao, Yi ^a   He, Ping ^f   Wang, Qing K ^g   Qi, Lu ^b   Hu, Frank B ^b   Liang, Liming ^b   Wu, Tangchun ^a   more..

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^c Department of Medicine   (United States)

^d ZHUHAI PEOPLE S HOSPITAL ZHUHAI HOSPITAL AFFILIATED WITH JINAN UNIVERSITY   (China)

^e Water Authority of Bao'an District   (China)

^f Wuhan Central Hospital   (China)

^g HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

acute coronary syndrome; coronary artery disease; DNA methylation; epigenomics; gene expression regulation; leukocytes; smoking

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; DNA; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ACUTE CORONARY SYNDROME; ADAPTIVE IMMUNITY; ADULT; ARTICLE; ATHEROGENESIS; B LYMPHOCYTE; CARDIOVASCULAR RISK; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL FUNCTION; CHEMOTAXIS; CONTROLLED STUDY; CORONARY ARTERY THROMBOSIS; DNA METHYLATION; DOWN REGULATION; FEMALE; GENE EXPRESSION; GENETIC ASSOCIATION; GENOME-WIDE ASSOCIATION STUDY; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SMOKING; AGED; BLOOD; CASE CONTROL STUDY; CHINA; GENETIC EPIGENESIS; GENETICS; MIDDLE AGED; PHYSIOLOGY; PROCEDURES;

ACUTE CORONARY SYNDROME; AGED; CASE-CONTROL STUDIES; CHINA; DNA METHYLATION; EPIGENESIS, GENETIC; FEMALE; GENOME-WIDE ASSOCIATION STUDY; HUMANS; MALE; MIDDLE AGED;

EID: 85016425264     PISSN: 00097330     EISSN: 15244571     Source Type: Journal    
DOI: 10.1161/CIRCRESAHA.116.310324     Document Type: Article

References (56)

1. O'Connor RE, Bossaert L, Arntz HR, Brooks SC, Diercks D, Feitosa-Filho G, Nolan JP, Vanden Hoek TL, Walters DL, Wong A, Welsford M, Woolfrey K; Acute Coronary Syndrome Chapter Collaborators. Part 9: acute coronary syndromes: 2010 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science With Treatment Recommendations. Circulation. 2010;122:S422-S465. doi: 10.1161/CIRCULATIONAHA.110.985549.
2. Libby P. Mechanisms of acute coronary syndromes and their implications for therapy. N Engl J Med. 2013;368:2004-2013. doi: 10.1056/ NEJMra1216063.
3. Deloukas P, Kanoni S, Willenborg C, et al; CARDIoGRAMplusC4D Consortium; DIAGRAM Consortium; CARDIOGENICS Consortium MuTHER Consortium; Wellcome Trust Case Control Consortium. Largescale association analysis identifies new risk loci for coronary artery disease. Nat Genet. 2013;45:25-33. doi: 10.1038/ng.2480.
4. Hansson GK. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med. 2005;352:1685-1695. doi: 10.1056/NEJMra043430.
5. Libby P, Tabas I, Fredman G, Fisher EA. Inflammation and its resolution as determinants of acute coronary syndromes. Circ Res. 2014;114:1867-1879. doi: 10.1161/CIRCRESAHA.114.302699.
6. Deaton AM, Bird A. CpG islands and the regulation of transcription. Genes Dev. 2011;25:1010-1022. doi: 10.1101/gad.2037511.
7. Egger G, Liang G, Aparicio A, Jones PA. Epigenetics in human disease and prospects for epigenetic therapy. Nature. 2004;429:457-463. doi: 10.1038/nature02625.
8. Liang L, Willis-Owen SA, Laprise C, et al. An epigenome-wide association study of total serum immunoglobulin E concentration. Nature. 2015;520:670-674. doi: 10.1038/nature14125.
9. Irvin MR, Zhi D, Joehanes R, et al. Epigenome-wide association study of fasting blood lipids in the Genetics of Lipid-lowering Drugs and Diet Network study. Circulation. 2014;130:565-572. doi: 10.1161/ CIRCULATIONAHA.114.009158.
10. Dick KJ, Nelson CP, Tsaprouni L, et al. DNA methylation and bodymass index: a genome-wide analysis. Lancet. 2014;383:1990-1998. doi: 10.1016/S0140-6736(13)62674-4.
11. Demerath EW, Guan W, Grove ML, et al. Epigenome-wide association study (EWAS) of BMI, BMI change and waist circumference in African American adults identifies multiple replicated loci. Hum Mol Genet. 2015;24:4464-4479. doi: 10.1093/hmg/ddv161.
12. De Jager PL, Srivastava G, Lunnon K, et al. Alzheimer's disease: early alterations in brain DNA methylation at ANK1, BIN1, RHBDF2 and other loci. Nat Neurosci. 2014;17:1156-1163. doi: 10.1038/nn.3786.
13. Zhong J, Agha G, Baccarelli AA. The role of DNA methylation in cardiovascular risk and disease: methodological aspects, study design, and data analysis for epidemiological studies. Circ Res. 2016;118:119-131. doi: 10.1161/CIRCRESAHA.115.305206.
14. Breitling LP, Salzmann K, Rothenbacher D, Burwinkel B, Brenner H. Smoking, F2RL3 methylation, and prognosis in stable coronary heart disease. Eur Heart J. 2012;33:2841-2848. doi: 10.1093/eurheartj/ehs091.
15. Alexeeff SE, Baccarelli AA, Halonen J, Coull BA, Wright RO, Tarantini L, Bollati V, Sparrow D, Vokonas P, Schwartz J. Association between blood pressure and DNA methylation of retrotransposons and pro-inflammatory genes. Int J Epidemiol. 2013;42:270-280. doi: 10.1093/ije/dys220.
16. Baccarelli A, Tarantini L, Wright RO, Bollati V, Litonjua AA, Zanobetti A, Sparrow D, Vokonas PS, Schwartz J. Repetitive element DNA methylation and circulating endothelial and inflammation markers in the VA normative aging study. Epigenetics. 2010;5:222-228.
17. Turunen MP, Aavik E, Ylä-Herttuala S. Epigenetics and atherosclerosis. Biochim Biophys Acta. 2009;1790:886-891. doi: 10.1016/j. bbagen.2009.02.008.
18. Baccarelli A, Wright R, Bollati V, Litonjua A, Zanobetti A, Tarantini L, Sparrow D, Vokonas P, Schwartz J. Ischemic heart disease and stroke in relation to blood DNA methylation. Epidemiology. 2010;21:819-828. doi: 10.1097/EDE.0b013e3181f20457.
19. Rask-Andersen M, Martinsson D, Ahsan M, Enroth S, Ek WE, Gyllensten U, Johansson Å. Epigenome-wide association study reveals differential DNA methylation in individuals with a history of myocardial infarction. Hum Mol Genet. 2016;25:4739-4748. doi: 10.1093/hmg/ddw302.
20. Yamada Y, Nishida T, Horibe H, Oguri M, Kato K, Sawabe M. Identification of hypo-and hypermethylated genes related to atherosclerosis by a genome-wide analysis of DNA methylation. Int J Mol Med. 2014;33:1355-1363. doi: 10.3892/ijmm.2014.1692.
21. Sharma P, Garg G, Kumar A, Mohammad F, Kumar SR, Tanwar VS, Sati S, Sharma A, Karthikeyan G, Brahmachari V, Sengupta S. Genome wide DNA methylation profiling for epigenetic alteration in coronary artery disease patients. Gene. 2014;541:31-40. doi: 10.1016/j. gene.2014.02.034.
22. Hansson GK, Libby P. The immune response in atherosclerosis: a doubleedged sword. Nat Rev Immunol. 2006;6:508-519. doi: 10.1038/nri1882.
23. Wright RS, Anderson JL, Adams CD, et al; American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. 2011 ACCF/AHA focused update incorporated into the ACC/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines developed in collaboration with the American Academy of Family Physicians, Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons. J Am Coll Cardiol. 2011;57:e215-e367. doi: 10.1016/j.jacc.2011.02.011.
24. O'Gara PT, Kushner FG, Ascheim DD, et al; American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation. 2013;127:e362-e425. doi: 10.1161/ CIR.0b013e3182742cf6.
25. Song Y, Hou J, Huang X, et al. The Wuhan-Zhuhai (WHZH) cohort study of environmental air particulate matter and the pathogenesis of cardiopulmonary diseases: study design, methods and baseline characteristics of the cohort. BMC Public Health. 2014;14:994. doi: 10.1186/1471-2458-14-994.
26. Leek JT, Johnson WE, Parker HS, Jaffe AE, Storey JD. The sva package for removing batch effects and other unwanted variation in highthroughput experiments. Bioinformatics. 2012;28:882-883. doi: 10.1093/ bioinformatics/bts034.
27. McGregor K, Bernatsky S, Colmegna I, Hudson M, Pastinen T, Labbe A, Greenwood CM. An evaluation of methods correcting for cell-type heterogeneity in DNA methylation studies. Genome Biol. 2016;17:84. doi: 10.1186/s13059-016-0935-y.
28. Sofer T, Schifano ED, Hoppin JA, Hou L, Baccarelli AA. A-clustering: a novel method for the detection of co-regulated methylation regions, and regions associated with exposure. Bioinformatics. 2013;29:2884-2891.
29. Gui L, Wu F, Han X, Dai X, Qiu G, Li J, Wang J, Zhang X, Wu T, He M. A multilocus genetic risk score predicts coronary heart disease risk in a Chinese Han population. Atherosclerosis. 2014;237:480-485. doi: 10.1016/j.atherosclerosis.2014.09.032.
30. Lee SH, Wray NR, Goddard ME, Visscher PM. Estimating missing heritability for disease from genome-wide association studies. Am J Hum Genet. 2011;88:294-305. doi: 10.1016/j.ajhg.2011.02.002.
31. Ma B, Wilker EH, Willis-Owen SA, Byun HM, Wong KC, Motta V, Baccarelli AA, Schwartz J, Cookson WO, Khabbaz K, Mittleman MA, Moffatt MF, Liang L. Predicting DNA methylation level across human tissues. Nucleic Acids Res. 2014;42:3515-3528. doi: 10.1093/nar/gkt1380.
32. Illumina. Manifest file of illumina methylation450k beadchip. 2016.
33. McLean CY, Bristor D, Hiller M, Clarke SL, Schaar BT, Lowe CB, Wenger AM, Bejerano G. GREAT improves functional interpretation of cis-regulatory regions. Nat Biotechnol. 2010;28:495-501. doi: 10.1038/ nbt.1630.
34. Reinius LE, Acevedo N, Joerink M, Pershagen G, Dahlén SE, Greco D, Söderhäll C, Scheynius A, Kere J. Differential DNA methylation in purified human blood cells: implications for cell lineage and studies on disease susceptibility. PLoS One. 2012;7:e41361. doi: 10.1371/journal. pone.0041361.
35. Grundberg E, Meduri E, Sandling JK, et al; Multiple Tissue Human Expression Resource Consortium. Global analysis of DNA methylation variation in adipose tissue from twins reveals links to disease-associated variants in distal regulatory elements. Am J Hum Genet. 2013;93:876-890. doi: 10.1016/j.ajhg.2013.10.004.
36. Rios FJ, Gidlund M, Jancar S. Pivotal role for platelet-activating factor receptor in CD36 expression and oxLDL uptake by human monocytes/ macrophages. Cell Physiol Biochem. 2011;27:363-372. doi: 10.1159/000327962.
37. Interleukin-6 Receptor Mendelian Randomisation Analysis C, Swerdlow DI, Holmes MV, et al. The interleukin-6 receptor as a target for prevention of coronary heart disease: a Mendelian randomisation analysis. Lancet. 2012;379:1214-1224.
38. Chen K, Febbraio M, Li W, Silverstein RL. A specific CD36-dependent signaling pathway is required for platelet activation by oxidized lowdensity lipoprotein. Circ Res. 2008;102:1512-1519. doi: 10.1161/ CIRCRESAHA.108.172064.
39. Anderson DR, Poterucha JT, Mikuls TR, Duryee MJ, Garvin RP, Klassen LW, Shurmur SW, Thiele GM. IL-6 and its receptors in coronary artery disease and acute myocardial infarction. Cytokine. 2013;62:395-400. doi: 10.1016/j.cyto.2013.03.020.
40. Elashoff MR, Wingrove JA, Beineke P, et al. Development of a bloodbased gene expression algorithm for assessment of obstructive coronary artery disease in non-diabetic patients. BMC Med Genomics. 2011;4:26. doi: 10.1186/1755-8794-4-26.
41. Yan W, Wang L, Jiang J, Xu W, Gong Z, Duan Q, Li C, Song H, Che L, Shen Y, Zhou L. Differential expression of T cell-related genes in AMI and SA stages of coronary artery disease. Int J Clin Exp Med. 2015;8:10875-10884.
42. Papaspyridonos M, Smith A, Burnand KG, Taylor P, Padayachee S, Suckling KE, James CH, Greaves DR, Patel L. Novel candidate genes in unstable areas of human atherosclerotic plaques. Arterioscler Thromb Vasc Biol. 2006;26:1837-1844. doi: 10.1161/01.ATV.0000229695.68416.76.
43. Hägg DA, Olson FJ, Kjelldahl J, JernÅs M, Thelle DS, Carlsson LM, Fagerberg B, Svensson PA. Expression of chemokine (C-C motif) ligand 18 in human macrophages and atherosclerotic plaques. Atherosclerosis. 2009;204:e15-e20. doi: 10.1016/j.atherosclerosis.2008.10.010.
44. Kraaijeveld AO, de Jager SC, de Jager WJ, Prakken BJ, McColl SR, Haspels I, Putter H, van Berkel TJ, Nagelkerken L, Jukema JW, Biessen EA. CC chemokine ligand-5 (CCL5/RANTES) and CC chemokine ligand-18 (CCL18/PARC) are specific markers of refractory unstable angina pectoris and are transiently raised during severe ischemic symptoms. Circulation. 2007;116:1931-1941. doi: 10.1161/CIRCULATIONAHA.107.706986.
45. de Jager SC, Bongaerts BW, Weber M, Kraaijeveld AO, Rousch M, Dimmeler S, van Dieijen-Visser MP, Cleutjens KB, Nelemans PJ, van Berkel TJ, Biessen EA. Chemokines CCL3/MIP1, CCL5/RANTES and CCL18/PARC are independent risk predictors of short-term mortality in patients with acute coronary syndromes. PLoS One. 2012;7:e45804. doi: 10.1371/journal.pone.0045804.
46. Joehanes R, Ying S, Huan T, Johnson AD, Raghavachari N, Wang R, Liu P, Woodhouse KA, Sen SK, Tanriverdi K, Courchesne P, Freedman JE, O'Donnell CJ, Levy D, Munson PJ. Gene expression signatures of coronary heart disease. Arterioscler Thromb Vasc Biol. 2013;33:1418-1426. doi: 10.1161/ATVBAHA.112.301169.
47. Grivel JC, Ivanova O, Pinegina N, Blank PS, Shpektor A, Margolis LB, Vasilieva E. Activation of T lymphocytes in atherosclerotic plaques. Arterioscler Thromb Vasc Biol. 2011;31:2929-2937. doi: 10.1161/ ATVBAHA.111.237081.
48. Kyaw T, Winship A, Tay C, Kanellakis P, Hosseini H, Cao A, Li P, Tipping P, Bobik A, Toh BH. Cytotoxic and proinflammatory CD8+ T lymphocytes promote development of vulnerable atherosclerotic plaques in apoE-deficient mice. Circulation. 2013;127:1028-1039. doi: 10.1161/ CIRCULATIONAHA.112.001347.
49. Gewaltig J, Kummer M, Koella C, Cathomas G, Biedermann BC. Requirements for CD8 T-cell migration into the human arterial wall. Hum Pathol. 2008;39:1756-1762. doi: 10.1016/j.humpath.2008.04.018.
50. Swirski FK, Nahrendorf M. Leukocyte behavior in atherosclerosis, myocardial infarction, and heart failure. Science. 2013;339:161-166. doi: 10.1126/science.1230719.
51. Madjid M, Awan I, Willerson JT, Casscells SW. Leukocyte count and coronary heart disease: implications for risk assessment. J Am Coll Cardiol. 2004;44:1945-1956. doi: 10.1016/j.jacc.2004.07.056.
52. Weng NP, Araki Y, Subedi K. The molecular basis of the memory T cell response: differential gene expression and its epigenetic regulation. Nat Rev Immunol. 2012;12:306-315. doi: 10.1038/nri3173.
53. Libby P, Lichtman AH, Hansson GK. Immune effector mechanisms implicated in atherosclerosis: from mice to humans. Immunity. 2013;38:1092-1104. doi: 10.1016/j.immuni.2013.06.009.
54. Byun HM, Siegmund KD, Pan F, Weisenberger DJ, Kanel G, Laird PW, Yang AS. Epigenetic profiling of somatic tissues from human autopsy specimens identifies tissue-and individual-specific DNA methylation patterns. Hum Mol Genet. 2009;18:4808-4817. doi: 10.1093/hmg/ ddp445.
55. Pugacheva EN, Golemis EA. The focal adhesion scaffolding protein HEF1 regulates activation of the Aurora-A and Nek2 kinases at the centrosome. Nat Cell Biol. 2005;7:937-946. doi: 10.1038/ncb1309.
56. Matsushita K, Iwanaga S, Oda T, Kimura K, Shimada M, Sano M, Umezawa A, Hata J, Ogawa S. Interleukin-6/soluble interleukin-6 receptor complex reduces infarct size via inhibiting myocardial apoptosis. Lab Invest. 2005;85:1210-1223. doi: 10.1038/labinvest. 3700322.